ストックスクリーナーアプリを入手
19.21
0.83%
-0.13
Legend Biotech Corp Adr (LEGN) 最新ニュース
Legend Biotech (NASDAQ:LEGN) Price Target Lowered to $50.00 at HC Wainwright - Defense World
Legend Biotech (NASDAQ:LEGN) Shares Gap Down on Analyst Downgrade - Defense World
H.C. Wainwright lowers Legend Biotech stock price target on Q4 sales miss By Investing.com - Investing.com South Africa
H.C. Wainwright lowers Legend Biotech stock price target on Q4 sales miss - Investing.com India
Rakuten Investment Management Inc. Takes $7.58 Million Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech stock rating downgraded by TD Cowen on Carvykti concerns - Investing.com South Africa
Legend Biotech (NASDAQ:LEGN) Hits New 52-Week LowHere's Why - MarketBeat
Legend Biotech stock hits 52-week low at $20.15 - Investing.com
Legend Biotech (NASDAQ:LEGN) Given “Outperform” Rating at Royal Bank Of Canada - Defense World
Raymond James reiterates Outperform rating on Legend Biotech stock By Investing.com - Investing.com India
Raymond James reiterates Outperform rating on Legend Biotech stock - Investing.com
Legend Biotech stock rises as FDA draft guidance supports accelerated approval endpoints By Investing.com - Investing.com South Africa
Legend Biotech stock rises as FDA draft guidance supports accelerated approval endpoints - Investing.com
Algonquin Power & Utilities Corp. (NYSE:AQN) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Short Interest in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Expands By 23.3% - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Short Interest Up 23.3% in December - MarketBeat
Deutsche Bank reiterates Buy rating on Legend Biotech stock with $60 target - Investing.com
LEGN: CARVYKTI's rapid growth, clinical leadership, and pipeline innovation drive 2026 profitability goals - TradingView — Track All Markets
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN) - Finviz
Legend Biotech (NASDAQ:LEGN) Coverage Initiated by Analysts at Oppenheimer - Defense World
Legend Biotech (NASDAQ:LEGN) Trading Up 7.3%What's Next? - MarketBeat
Legend Biotech (NASDAQ:LEGN) Reaches New 12-Month LowWhat's Next? - MarketBeat
Legend Biotech stock hits 52-week low at 21.16 USD - Investing.com
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Matthews International Capital Management LLC - MarketBeat
Connective Portfolio Management LLC Acquires New Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Legend Biotech (LEGN) – Investment Analysts’ Recent Ratings Changes - Defense World
Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares - The Motley Fool
Here is Why Legend Biotech (LEGN) Offers Such Promising Upside - Finviz
Legend Biotech stock remains Overweight at Cantor Fitzgerald despite YTD decline By Investing.com - Investing.com South Africa
Legend Biotech stock remains Overweight at Cantor Fitzgerald despite YTD decline - Investing.com India
Legend Biotech (NASDAQ:LEGN) Reaches New 52-Week LowWhat's Next? - MarketBeat
Legend Biotech stock hits 52-week low at $22.27 - Investing.com
Squarepoint Ops LLC Grows Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Braidwell LP - MarketBeat
Jump Financial LLC Increases Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects - Finviz
Nothing is Better Than Harrow Inc (HROW) stock at the moment - Setenews
Ready to Jump After Recent Trade: Venture Global Inc (VG) - setenews.com
Stempoint Capital LP Takes $9.59 Million Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech stock remains Outperform at RBC despite competitive threats By Investing.com - Investing.com South Africa
Legend Biotech (NASDAQ:LEGN) Trading Down 4.7%Time to Sell? - MarketBeat
Legend Biotech stock remains Outperform at RBC despite competitive threats - Investing.com
Federated Hermes Inc. Has $37.75 Million Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech (NASDAQ:LEGN) Sets New 12-Month LowWhat's Next? - MarketBeat
Legend Biotech stock hits 52-week low at $25.66 By Investing.com - Investing.com South Africa
Legend Biotech stock hits 52-week low at $25.66 - Investing.com
Legend Biotech stock maintains Outperform rating at RBC on Carvykti efficacy - Investing.com India
Legend Biotech Corporation Sponsored ADR $LEGN Shares Purchased by New York State Common Retirement Fund - MarketBeat
Schroder Investment Management Group Has $6.74 Million Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
A Look at Dutch Bros Inc (BROS) Shares in the Recent Past Indicates Growth - setenews.com
Decheng Capital LLC Sells 80,000 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Hsbc Holdings PLC Has $16.90 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
4.38%
1.75%
大文字化:
|
ボリューム (24 時間):